This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Eikonizo Therapeutics, Inc., Psy Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Jacob Matthew Hooker: Innovator in Monoacylglycerol Lipase Inhibition
Introduction
Jacob Matthew Hooker is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of monoacylglycerol lipase (MAGL) inhibition. His work has the potential to impact various therapeutic applications.
Latest Patents
Jacob Matthew Hooker holds a patent for inhibiting monoacylglycerol lipase (MAGL). The patent provides compounds for inhibiting MAGL, along with related methods for making and using these compounds. This innovation is crucial for advancing research in metabolic disorders and pain management.
Career Highlights
Jacob is currently associated with Psy Therapeutics, Inc., where he applies his expertise in developing therapeutic solutions. His role at the company allows him to further explore the implications of his patent in real-world applications.
Conclusion
Jacob Matthew Hooker is a dedicated inventor whose work in inhibiting monoacylglycerol lipase showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile